Exchange Announcement • 08 Oct 2026 16:00
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Exchange Announcement • 31 Jul 2026 11:00
Consolidated Financial Results For The First Quarter Of Fiscal Year Ending March 31, 2027 (Ifrs)
Exchange Announcement • 10 Jul 2026 11:00
Notice Concerning Completion Of Disposal Of Treasury Shares As Tenure-Based Restricted Stock Compensation And Performance-Linked Restricted Stock Comp
Exchange Announcement • 18 Jun 2026 15:30
Notice Of Disposal Of Treasury Shares As Tenure-Based Restricted Stock Compensation And Performance-Linked Restricted Stock Compensation
Exchange Announcement • 08 May 2026 11:00